Common NameRiboflavin
DescriptionFlavin mononucleotide (FMN), or riboflavin-5′-phosphate, is a biomolecule produced from riboflavin (vitamin B2) by the enzyme riboflavin kinase and functions as the prosthetic group of various oxidoreductases, including NADH dehydrogenase, as well as cofactor in biological blue-light photo receptors. During the catalytic cycle, a reversible interconversion of the oxidized (FMN), semiquinone (FMNH), and reduced (FMNH2) forms occurs in the various oxidoreductases. FMN is a stronger oxidizing agent than NAD and is particularly useful because it can take part in both one- and two-electron transfers. In its role as blue-light photo receptor, (oxidized) FMN stands out from the 'conventional' photo receptors as the signaling state and not an E/Z isomerization. It is the principal form in which riboflavin is found in cells and tissues. It requires more energy to produce, but is more soluble than riboflavin. Flavin mononucleotide belongs to the class of organic compounds known as flavin nucleotides. These are nucleotides containing a flavin moiety. Flavin is a compound that contains the tricyclic isoalloxazine ring system, which bears 2 oxo groups at the 2- and 4-positions. Flavin mononucleotide exists in all living species, ranging from bacteria to humans. Within humans, flavin mononucleotide participates in a number of enzymatic reactions. In particular, formic acid and flavin mononucleotide can be biosynthesized from FMNH2; which is catalyzed by the enzyme lanosterol 14-alpha demethylase. In addition, formic acid and flavin mononucleotide can be biosynthesized from FMNH2 through the action of the enzyme lanosterol 14-alpha demethylase. In humans, flavin mononucleotide is involved in bloch pathway (cholesterol biosynthesis). Outside of the human body, flavin mononucleotide has been detected, but not quantified in several different foods, such as mandarin orange (clementine, tangerine), horseradish tree, black elderberries, angelica, and ostrich ferns.
Structure
Molecular FormulaC17H21N4O9P
Average Mass456.34380
Monoisotopic Mass456.10461
IUPAC Name{[(2R,3S,4S)-5-{7,8-dimethyl-2,4-dioxo-2H,3H,4H,10H-benzo[g]pteridin-10-yl}-2,3,4-trihydroxypentyl]oxy}phosphonic acid
Traditional Name[(2r,3s,4s)-5-{7,8-dimethyl-2,4-dioxo-3h-benzo[g]pteridin-10-yl}-2,3,4-trihydroxypentyl]oxyphosphonic acid
CAS Registry Number146-17-8
SMILESCc1cc2nc3c(=O)[n-]c(=O)nc-3n(C[C@H](O)[C@H](O)[C@H](O)CO)c2cc1C
InChI IdentifierInChI=1S/C17H21N4O9P/c1-7-3-9-10(4-8(7)2)21(15-13(18-9)16(25)20-17(26)19-15)5-11(22)14(24)12(23)6-30-31(27,28)29/h3-4,11-12,14,22-24H,5-6H2,1-2H3,(H,20,25,26)(H2,27,28,29)/t11-,12+,14-/m0/s1
InChI KeyFVTCRASFADXXNN-SCRDCRAPSA-N
CHEBI IDCHEBI:57986
HMDB IDHMDB0001520
Pathways
NameSMPDB/PathBank
beta-Alanine metabolism
Pyrimidine metabolism
Arginine and proline metabolism
Vitamin B6 Metabolism
Pantothenate and CoA Biosynthesis
Riboflavin Metabolism
Beta Ureidopropionase Deficiency
Dihydropyrimidinase Deficiency
Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)
MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy)
Prolidase Deficiency (PD)
Prolinemia Type II
UMP Synthase Deficiency (Orotic Aciduria)
GABA-Transaminase Deficiency
Hyperprolinemia Type II
Hyperprolinemia Type I
Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)
Ornithine Aminotransferase Deficiency (OAT Deficiency)
Ureidopropionase Deficiency
Carnosinuria, carnosinemia
Hypophosphatasia
Creatine deficiency, guanidinoacetate methyltransferase deficiency
Hyperornithinemia with gyrate atrophy (HOGA)
Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]
L-arginine:glycine amidinotransferase deficiency
Doxorubicin Metabolism Pathway
StateSolid
Water Solubility6.68e-01 g/l
logP-0.78
logS-2.83
pKa (Strongest Acidic)1.57
pKa (Strongest Basic)0.68
Hydrogen Acceptor Count11
Hydrogen Donor Count6
Polar Surface Area201.58 Ų
Rotatable Bond Count7
Physiological Charge-3
Formal Charge0
Refractivity107.14 m³·mol⁻¹
Polarizability42.19

We require the use of cookies for essential features like storing your previously submitted BASys2 queries. Rejecting the usage of cookies will result in certain features being disabled. By clicking ACCEPT or continuing to use the website you are agreeing to our use of cookies.

ACCEPT